TARDBP and Alzheimer disease: The 2 groups with more advanced clinical than biological staging showed evidence of higher levels of non–AD brain pathologies (eg, α-synuclein positivity, more advanced TDP-43-like signature, and higher load of WMHs), higher NfL levels, and they were older.